Centro Oncológico Riojano Integral ( Site 0256)
La Rioja X5004BAL
1 studies enrolling now · 1 studies all time
What they study most
Carcinoma, Renal Cell
Studies at this site
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
— Recruiting now